• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mycobacterium canettii is intrinsically resistant to both pyrazinamide and pyrazinoic acid.

作者信息

Feuerriegel Silke, Köser Claudio U, Richter Elvira, Niemann Stefan

出版信息

J Antimicrob Chemother. 2013 Jun;68(6):1439-40. doi: 10.1093/jac/dkt042. Epub 2013 Feb 26.

DOI:10.1093/jac/dkt042
PMID:23447141
Abstract
摘要

相似文献

1
Mycobacterium canettii is intrinsically resistant to both pyrazinamide and pyrazinoic acid.卡内蒂分枝杆菌对吡嗪酰胺和吡嗪酸均具有内在抗性。
J Antimicrob Chemother. 2013 Jun;68(6):1439-40. doi: 10.1093/jac/dkt042. Epub 2013 Feb 26.
2
Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications: Identification of a species-specific pncA mutation in "Mycobacterium canettii" and the reliable and rapid predictor of pyrazinamide resistance.结核分枝杆菌复合群成员中pncA基因的测序具有重要的诊断应用：鉴定“堪萨斯分枝杆菌”中物种特异性的pncA突变以及吡嗪酰胺耐药性的可靠快速预测指标。
J Clin Microbiol. 2007 Feb;45(2):595-9. doi: 10.1128/JCM.01454-06. Epub 2006 Nov 29.
3
Missense Mutations in the Unfoldase ClpC1 of the Caseinolytic Protease Complex Are Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis.酪蛋白水解蛋白酶复合体的解折叠酶ClpC1中的错义突变与结核分枝杆菌对吡嗪酰胺的耐药性相关。
Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.02342-16. Print 2017 Feb.
4
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.巴西耐吡嗪酰胺结核分枝杆菌中pncA基因突变的特征分析
Antimicrob Agents Chemother. 2005 Jan;49(1):444-6. doi: 10.1128/AAC.49.1.444-446.2005.
5
A simplified pyrazinamidase test for pyrazinamide drug susceptibility in Mycobacterium tuberculosis.一种用于检测结核分枝杆菌对吡嗪酰胺药物敏感性的简化吡嗪酰胺酶试验。
J Microbiol Methods. 2018 Nov;154:52-54. doi: 10.1016/j.mimet.2018.09.018. Epub 2018 Oct 11.
6
The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms.来自天然耐吡嗪酰胺的鸟分枝杆菌的pncA基因编码吡嗪酰胺酶，并赋予耐吡嗪酰胺的结核分枝杆菌复合群菌株对吡嗪酰胺的敏感性。
Microbiology (Reading). 1997 Oct;143 ( Pt 10):3367-3373. doi: 10.1099/00221287-143-10-3367.
7
Identification of Novel Mutations in LprG (), , , , , and Associated with Pyrazinoic Acid/Pyrazinamide Resistance in Mycobacterium tuberculosis.鉴定与结核分枝杆菌吡嗪酸/吡嗪酰胺耐药相关的 LprG () 、 、 、 、 和 中的新型突变。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00430-18. Print 2018 Jul.
8
In vitro antimycobacterial activities of pyrazinamide analogs.吡嗪酰胺类似物的体外抗分枝杆菌活性。
Antimicrob Agents Chemother. 1995 Sep;39(9):2088-91. doi: 10.1128/AAC.39.9.2088.
9
Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.巴基斯坦开伯尔-普赫图赫瓦省结核分枝杆菌分离株中吡嗪酰胺耐药性及 pncA 基因突变。
BMC Infect Dis. 2019 Feb 6;19(1):116. doi: 10.1186/s12879-019-3764-2.
10
Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms.结核分枝杆菌复合群生物体中与吡嗪酰胺耐药相关的pncA基因突变。
Antimicrob Agents Chemother. 1997 Mar;41(3):636-40. doi: 10.1128/AAC.41.3.636.

引用本文的文献

1
A smooth tubercle bacillus from Ethiopia phylogenetically close to the Mycobacterium tuberculosis complex.从埃塞俄比亚分离到的与结核分枝杆菌复合体亲缘关系密切的光滑型结核分枝杆菌。
Nat Commun. 2023 Nov 18;14(1):7519. doi: 10.1038/s41467-023-42755-9.
2
A pro-oxidant property of vitamin C to overcome the burden of latent infection: A cross-talk review with Fenton reaction.维生素 C 的促氧化剂特性可克服潜伏性感染的负担：与芬顿反应的交叉对话综述。
Front Cell Infect Microbiol. 2023 Apr 19;13:1152269. doi: 10.3389/fcimb.2023.1152269. eCollection 2023.
3
Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line.
结核分枝杆菌对一线药物耐药的分子机制的突变与见解。
Genet Mol Biol. 2023 Jan 23;46(1 Suppl 2):e20220261. doi: 10.1590/1678-4685-GMB-2022-0261. eCollection 2023.
4
induced human tuberculosis in India: Current status, challenges & opportunities.在印度诱导人类结核病：现状、挑战和机遇。
Indian J Med Res. 2022 Jul;156(1):21-30. doi: 10.4103/ijmr.IJMR_1161_19.
5
Evaluation of PCR -restriction fragment length polymorphism and PCR amplification of genomic regions of difference for the identification of strains in lymph nodes cultures.聚合酶链反应-限制性片段长度多态性评估和基因组区域差异的聚合酶链反应扩增在淋巴结培养物中鉴定 株。
Afr Health Sci. 2021 Sep;21(3):985-989. doi: 10.4314/ahs.v21i3.4.
6
ESX-1-Independent Horizontal Gene Transfer by Mycobacterium tuberculosis Complex Strains.结核分枝杆菌复合群菌株的 ESX-1 独立水平基因转移。
mBio. 2021 May 18;12(3):e00965-21. doi: 10.1128/mBio.00965-21.
7
How To Optimally Combine Genotypic and Phenotypic Drug Susceptibility Testing Methods for Pyrazinamide.如何优化吡嗪酰胺基因型和表型药敏试验方法的联合应用
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.01003-20.
8
Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex.结核分枝杆菌复合体中与抗生素耐药性相关基因的系统发育信息性突变。
Genome Med. 2020 Mar 6;12(1):27. doi: 10.1186/s13073-020-00726-5.
9
Antibiotic resistance genes in the Actinobacteria phylum.放线菌门中的抗生素耐药基因。
Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1599-1624. doi: 10.1007/s10096-019-03580-5. Epub 2019 Jun 27.
10
Revised Interpretation of the Hain Lifescience GenoType MTBC To Differentiate and Members of the Mycobacterium tuberculosis Complex.海能生科 MTBC 基因分型检测试剂盒（反向斑点杂交法）用于区分结核分枝杆菌复合群及分枝杆菌菌种的修订解释。
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.00159-19. Print 2019 Jun.